These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 20167488)

  • 1. The design and development of 2-aryl-2-hydroxy ethylamine substituted 1H,7H-pyrido[1,2,3-de]quinoxaline-6-carboxamides as inhibitors of human cytomegalovirus polymerase.
    Tanis SP; Strohbach JW; Parker TT; Moon MW; Thaisrivongs S; Perrault WR; Hopkins TA; Knechtel ML; Oien NL; Wieber JL; Stephanski KJ; Wathen MW
    Bioorg Med Chem Lett; 2010 Mar; 20(6):1994-2000. PubMed ID: 20167488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of pyrrolidine-5,5'-trans-lactams (5-oxo-hexahydropyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 4. Antiviral activity and plasma stability.
    Borthwick AD; Davies DE; Ertl PF; Exall AM; Haley TM; Hart GJ; Jackson DL; Parry NR; Patikis A; Trivedi N; Weingarten GG; Woolven JM
    J Med Chem; 2003 Oct; 46(21):4428-49. PubMed ID: 14521407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The herpesvirus protease: mechanistic studies and discovery of inhibitors of the human cytomegalovirus protease.
    Flynn DL; Becker DP; Dilworth VM; Highkin MK; Hippenmeyer PJ; Houseman KA; Levine LM; Li M; Moormann AE; Rankin A; Toth MV; Villamil CI; Wittwer AJ; Holwerda BC
    Drug Des Discov; 1997 May; 15(1):3-15. PubMed ID: 9332827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antiviral activity of monobactams inhibiting the human cytomegalovirus protease.
    Ogilvie WW; Yoakim C; Dô F; Haché B; Lagacé L; Naud J; O'Meara JA; Déziel R
    Bioorg Med Chem; 1999 Aug; 7(8):1521-31. PubMed ID: 10482444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-nucleoside inhibitors of herpesviruses.
    Wathen MW
    Rev Med Virol; 2002; 12(3):167-78. PubMed ID: 11987142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of translactam HCMV protease inhibitors as potent antivirals.
    Borthwick AD
    Med Res Rev; 2005 Jul; 25(4):427-52. PubMed ID: 15789440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From 1-acyl-beta-lactam human cytomegalovirus protease inhibitors to 1-benzyloxycarbonylazetidines with improved antiviral activity. A straightforward approach to convert covalent to noncovalent inhibitors.
    Gerona-Navarro G; Pérez de Vega MJ; García-López MT; Andrei G; Snoeck R; De Clercq E; Balzarini J; González-Muñiz R
    J Med Chem; 2005 Apr; 48(7):2612-21. PubMed ID: 15801851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4-Oxo-4,7-dihydrothieno[2,3-b]pyridines as non-nucleoside inhibitors of human cytomegalovirus and related herpesvirus polymerases.
    Schnute ME; Cudahy MM; Brideau RJ; Homa FL; Hopkins TA; Knechtel ML; Oien NL; Pitts TW; Poorman RA; Wathen MW; Wieber JL
    J Med Chem; 2005 Sep; 48(18):5794-804. PubMed ID: 16134946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological activity of 7H-benzo[4,5]indolo[2,3-b]-quinoxaline derivatives.
    Shibinskaya MO; Karpenko AS; Lyakhov SA; Andronati SA; Zholobak NM; Spivak NY; Samochina NA; Shafran LM; Zubritsky MJ; Galat VF
    Eur J Med Chem; 2011 Feb; 46(2):794-8. PubMed ID: 21172726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a practical, asymmetric synthesis of the hepatitis C virus protease inhibitor MK-5172.
    Kuethe J; Zhong YL; Yasuda N; Beutner G; Linn K; Kim M; Marcune B; Dreher SD; Humphrey G; Pei T
    Org Lett; 2013 Aug; 15(16):4174-7. PubMed ID: 23919347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of amino-substituted benzo[f]pyrido[4,3-b] and pyrido[3,4-b]quinoxalines: a new class of antineoplastic agents.
    Nguyen CH; Fan E; Riou JF; Bissery MC; Vrignaud P; Lavelle F; Bisagni E
    Anticancer Drug Des; 1995 Jun; 10(4):277-97. PubMed ID: 7786395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptidomimetic therapeutic agents targeting the protease enzyme of the human immunodeficiency virus and hepatitis C virus.
    Tsantrizos YS
    Acc Chem Res; 2008 Oct; 41(10):1252-63. PubMed ID: 18681464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of 4-oxo-4,7-dihydrofuro[2,3-b]pyridine-5-carboxamides with broad-spectrum human herpesvirus polymerase inhibition.
    Schnute ME; Brideau RJ; Collier SA; Cudahy MM; Hopkins TA; Knechtel ML; Oien NL; Sackett RS; Scott A; Stephan ML; Wathen MW; Wieber JL
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3856-9. PubMed ID: 18595689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4-Benzyloxy-gamma-sultone derivatives: discovery of a novel family of non-nucleoside inhibitors of human cytomegalovirus and varicella zoster virus.
    De Castro S; García-Aparicio C; Andrei G; Snoeck R; Balzarini J; Camarasa MJ; Velázquez S
    J Med Chem; 2009 Mar; 52(6):1582-91. PubMed ID: 19226140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. beta-Lactam derivatives as inhibitors of human cytomegalovirus protease.
    Yoakim C; Ogilvie WW; Cameron DR; Chabot C; Guse I; Haché B; Naud J; O'Meara JA; Plante R; Déziel R
    J Med Chem; 1998 Jul; 41(15):2882-91. PubMed ID: 9667976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-Aryl-2-hydroxyethylamine substituted 4-oxo-4,7-dihydrothieno[2,3-b]pyridines as broad-spectrum inhibitors of human herpesvirus polymerases.
    Schnute ME; Anderson DJ; Brideau RJ; Ciske FL; Collier SA; Cudahy MM; Eggen M; Genin MJ; Hopkins TA; Judge TM; Kim EJ; Knechtel ML; Nair SK; Nieman JA; Oien NL; Scott A; Tanis SP; Vaillancourt VA; Wathen MW; Wieber JL
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3349-53. PubMed ID: 17434304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and syntheses of 1,6-naphthalene derivatives as selective HCMV protease inhibitors.
    Gopalsamy A; Lim K; Ellingboe JW; Mitsner B; Nikitenko A; Upeslacis J; Mansour TS; Olson MW; Bebernitz GA; Grinberg D; Feld B; Moy FJ; O'Connell J
    J Med Chem; 2004 Apr; 47(8):1893-9. PubMed ID: 15055990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance profiling of hepatitis C virus protease inhibitors using full-length NS3.
    Dahl G; Sandström A; Akerblom E; Danielson UH
    Antivir Ther; 2007; 12(5):733-40. PubMed ID: 17713156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4"-Benzoylureido-TSAO derivatives as potent and selective non-nucleoside HCMV inhibitors. Structure-activity relationship and mechanism of antiviral action.
    de Castro S; Peromingo MT; Naesens L; Andrei G; Snoeck R; Balzarini J; Velázquez S; Camarasa MJ
    J Med Chem; 2008 Sep; 51(18):5823-32. PubMed ID: 18707089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptidomimetic inhibitors of the human cytomegalovirus protease.
    Ogilvie W; Bailey M; Poupart MA; Abraham A; Bhavsar A; Bonneau P; Bordeleau J; Bousquet Y; Chabot C; Duceppe JS; Fazal G; Goulet S; Grand-Maître C; Guse I; Halmos T; Lavallée P; Leach M; Malenfant E; O'Meara J; Plante R; Plouffe C; Poirier M; Soucy F; Yoakim C; Déziel R
    J Med Chem; 1997 Dec; 40(25):4113-35. PubMed ID: 9406601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.